Bellerophon Therapeutics, Inc. Stock Split Ratio
Bellerophon Therapeutics, Inc. had Stock Split Ratio of 6.67% as of 2020-02-07, per its 10-K filed 2023-03-31.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2023-03-31
- 2020-02-07: Stockholders' Equity Note, Stock Split, Conversion Ratio 6.67%.
- 2015-02-02: Stockholders' Equity Note, Stock Split, Conversion Ratio 7.98%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2020-02-07 | 6.67% 10-K · filed 2023-03-31 |
| 2015-02-02 | 7.98% 10-K · filed 2017-03-13 |